Evidence map›Paper›PMID 35022767›Full record

ReviewNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association2023

Overcoming barriers in the design and implementation of clinical trials for acute kidney injury: a report from the 2020 Kidney Disease Clinical Trialists meeting.

Daniel Lazzareschi, Ravindra L Mehta, Laura M Dember, Juliane Bernholz, Alparslan Turan, Amit Sharma, Sachin Kheterpal, Chirag R Parikh, Omar Ali, Ivonne H Schulman and 6 more

Abstract readReview
In one paragraph

Review in Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. [Clinical sub-phenotypes of acute kidney injury in children and their association with prognosis].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Water Extract from Brown Strain ofInternational journal of molecular sciences · 2023
    Article
  12. Article
  13. Review
  14. Subphenotypes in acute kidney injury: a narrative review.Critical care (London, England) · 2022
    Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Daniel LazzareschiDepartment of Anesthesia & Perioperative Care, Division of Critical Care Medicine, University of California, San Francisco (UCSF), San Francisco, CA, USA.
Ravindra L MehtaDepartment of Medicine, University of California, San Diego, San Diego, CA, USA.
Laura M DemberRenal-Electrolyte and Hypertension Division, Department of Medicine, Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania Perelman School of Medicine, Pennsylvania, PA, USA.
Juliane BernholzAM-Pharma, Utrecht, The Netherlands.
Alparslan TuranDepartment of Anesthesiology, Lerner College of Medicine of Case Western University, Cleveland, OH, USA.
Amit SharmaBayer Pharmaceuticals, Cambridge, MA, USA.
Sachin KheterpalDepartment of Anesthesiology, University of Michigan, Ann Arbor, MI, USA.
Chirag R ParikhDepartment of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA.ORCID 0000-0001-9051-7385
Omar AliVerpora Ltd, Nottingham, UK.
Ivonne H SchulmanNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, MD, USA.
Abigail RyanDivision of Chronic Care Management, Centers for Medicare & Medicaid Services, Woodlawn, MD, USA.
Jean FengDepartment of Epidemiology and Biostatistics, University of California, San Francisco (UCSF), San Francisco, CA, USA.
Noah SimonDepartment of Biostatistics, University of Washington (UW), Seattle, WA, USA.
Romain PirracchioDepartment of Anesthesia & Perioperative Care, Division of Critical Care Medicine, University of California, San Francisco (UCSF), San Francisco, CA, USA.
Patrick RossignolINI-CRCT Network, Nancy, France.
Matthieu LegrandDepartment of Anesthesia & Perioperative Care, Division of Critical Care Medicine, University of California, San Francisco (UCSF), San Francisco, CA, USA.ORCID 0000-0001-9788-5316

Funding

Continuation of the Coordinating Center for the Chronic Renal Insufficiency Cohort (CRIC) StudyU24DK060990 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI Amanda Hyre Anderson, Laura M Dember · 2018 to 2026
$21.5M
Novel Biomarkers in Cardiac Surgery to Detect Acute Kidney InjuryR01HL085757 · NHLBI · YALE UNIVERSITY · PI PARIKH, CHIRAG R · 2007 to 2019
$10.3M
Novel Kidney Injury Tools in Deceased Organ Donation to Predict Graft OutcomesR01DK093770 · NIDDK · YALE UNIVERSITY · PI Chirag R Parikh · 2012 to 2026
$9.5M
Leveraging Clinical Trials of Diabetic Kidney Disease to Advance BiomarkersU01DK106962 · NIDDK · YALE UNIVERSITY · PI COCA, STEVEN G, PARIKH, CHIRAG R · 2015 to 2019
$1.3M
AKI Matched Phenotype Linked Evaluation with Tissue (AMPLE-Tissue)UH3DK114866 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI PARIKH, CHIRAG R · 2019 to 2021
$900k
NHLBI NIH HHS R01 HL085757NIDDK NIH HHS R01 DK093770NIDDK NIH HHS U01 DK106962NIDDK NIH HHS U24 DK060990NIDDK NIH HHS UH3 DK114866
6 · The paper itself

Abstract

Acute kidney injury (AKI) is a growing epidemic and is independently associated with increased risk of death, chronic kidney disease (CKD) and cardiovascular events. Randomized-controlled trials (RCTs) in this domain are notoriously challenging and many clinical studies in AKI have yielded inconclusive findings. Underlying this conundrum is the inherent heterogeneity of AKI in its etiology, presentation and course. AKI is best understood as a syndrome and identification of AKI subphenotypes is needed to elucidate the disease's myriad etiologies and to tailor effective prevention and treatment strategies. Conventional RCTs are logistically cumbersome and often feature highly selected patient populations that limit external generalizability and thus alternative trial designs should be considered when appropriate. In this narrative review of recent developments in AKI trials based on the Kidney Disease Clinical Trialists (KDCT) 2020 meeting, we discuss barriers to and strategies for improved design and implementation of clinical trials for AKI patients, including predictive and prognostic enrichment techniques, the use of pragmatic trials and adaptive trials.

Indexed as

Acute Kidney InjuryAdaptive Clinical Trials as TopicHumansPrognosisAKIbiomarkersmachine learningoutcomepragmatic trial

Identifiers

PMID35022767
PMCPMC10064977

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.